Eren Yasemin, Yavasoglu Nese Gungor, Ozisler Cem
Diskapi Yildirim Beyazit Training and Research Hospital, Neurology, Health Sciences University, Ankara, Turkey.
Diskapi Yildirim Beyazit Training and Research Hospital, Rheumatology, Health Sciences University, Ankara, Turkey.
Neurol Res. 2020 Jan;42(1):17-21. doi: 10.1080/01616412.2019.1680126. Epub 2019 Oct 29.
: Polyneuropathy is the most common neurological complication in primary Sjögren's syndrome (pSS). A ratio of sural nerve and superficial radial nerve sensorial action potential amplitudes (SRARs) of <0.4 is an indicator for early axonal neuropathy. We evaluated the polyneuropathies and SRARs in pSS patients.: Fifty-two female patients who were diagnosed with pSS according to the European-American Consensus Criteria and 45 healthy controls were enrolled. Nerve conduction studies were performed to diagnose polyneuropathy. Sensory axonal polyneuropathy was diagnosed in three patients, so SRARs were compared in 49 patients and 50 healthy controls.: Fifty-two patients with pSS underwent nerve conduction tests. The sural sensory nerve action potential (SNAP) was <6 µV in threepatients and they were diagnosed with sensory axonal neuropathy. SRARs were evaluated in 49 female patients, with a mean age of 51.98 ± 10.79 years and 50 healthy controls with a mean age of 50.52 ± 12.55 years. The mean disease duration was 7.59 ± 6.17 years. The SRAR values were different between the patient and control groups. SRAR was <0.4 in 20.4% of the patient group and <0.4 in 6% of the control group. The SRAR value was not statistically different within the patient group based on anti-Ro and anti-La.: The potential for neurological involvement in patients with pSS who have no signs or injury should be evaluated because nervous system involvement in pSS is a negative prognostic factor. SRAR in patients with pSS can be used as a marker for the early detection of axonal neuropathy.
多发性神经病是原发性干燥综合征(pSS)最常见的神经并发症。腓肠神经与桡浅神经感觉动作电位幅度之比(SRARs)<0.4是早期轴索性神经病的一个指标。我们评估了pSS患者的多发性神经病和SRARs。
纳入了52例根据欧美共识标准诊断为pSS的女性患者和45例健康对照。进行神经传导研究以诊断多发性神经病。3例患者被诊断为感觉轴索性多发性神经病,因此在49例患者和50例健康对照中比较了SRARs。
52例pSS患者接受了神经传导测试。3例患者的腓肠感觉神经动作电位(SNAP)<6µV,他们被诊断为感觉轴索性神经病。对49例平均年龄为51.98±10.79岁的女性患者和50例平均年龄为50.52±12.55岁的健康对照进行了SRARs评估。平均病程为7.59±6.17年。患者组和对照组的SRAR值不同。患者组中20.4%的SRAR<0.4,对照组中6%的SRAR<0.4。基于抗Ro和抗La,患者组内的SRAR值无统计学差异。
对于无体征或损伤的pSS患者,应评估其神经受累的可能性,因为pSS中的神经系统受累是一个不良预后因素。pSS患者的SRAR可作为早期检测轴索性神经病的标志物。